Jason Springs is currently the CEO of GeneWeave Biosciences, LLC. His company develops diagnostic devices that detect the presence and drug-resistance of disease-causing bacteria without the need for a diagnostic laboratory. The company is particularly focused on detecting so-called "superbugs" -disease-causing bacteria that are resistant or immune to standard antibiotics, as well as bacteria responsible for many hospital-acquired infections (HAIs).
Jason Springs is a first year MBA student at the Johnson School at Cornell University. He received his undergraduate degree in Economics and Management from the University of South Carolina.
The other side is an operations plan, you know, if someone really a description of if we were to receive half a million dollars or million dollars, five million dollars, what would we do? You know what happens in one month, what happens in two months, six months, a year if all of a sudden the econo...(Full transcript available to logged in subscribers.).
Register & Subscribe
Login